Ensign Peak Advisors
CVS icon

Ensign Peak Advisors’s CVS Health CVS Stock Holding History

Ensign Peak Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.5M Buy
758,947
+20,767
+3% +$1.85M 0.13% 148
2026
Q1 		$53M Buy
738,180
+30,934
+4% +$2.38M 0.1% 177
2025
Q4 		$56.1M Sell
707,246
-104,049
-13% -$8.2M 0.1% 173
2025
Q3 		$61.2M Buy
811,295
+218,586
+37% +$15M 0.1% 176
2025
Q2 		$40.9M Sell
592,709
-416,407
-41% -$27.3M 0.07% 220
2025
Q1 		$68.4M Buy
1,009,116
+488,619
+94% +$29.2M 0.13% 154
2024
Q4 		$23.4M Sell
520,497
-211,195
-29% -$11.8M 0.04% 293
2024
Q3 		$46M Sell
731,692
-105,055
-13% -$6.13M 0.08% 199
2024
Q2 		$49.4M Sell
836,747
-201,264
-19% -$12.6M 0.09% 185
2024
Q1 		$82.8M Sell
1,038,011
-29,692
-3% -$2.27M 0.15% 134
2023
Q4 		$84.3M Buy
1,067,703
+153,000
+17% +$10.9M 0.17% 121
2023
Q3 		$63.9M Sell
914,703
-7,264
-0.8% -$515K 0.14% 139
2023
Q2 		$63.7M Sell
921,967
-197,058
-18% -$14M 0.13% 143
2023
Q1 		$83.2M Sell
1,119,025
-11,586
-1% -$972K 0.18% 115
2022
Q4 		$105M Sell
1,130,611
-49,815
-4% -$4.81M 0.24% 96
2022
Q3 		$113M Buy
1,180,426
+30,313
+3% +$3M 0.28% 89
2022
Q2 		$107M Buy
1,150,113
+46,384
+4% +$4.53M 0.25% 97
2022
Q1 		$112M Buy
1,103,729
+73,369
+7% +$7.71M 0.23% 102
2021
Q4 		$106M Sell
1,030,360
-446,467
-30% -$41.3M 0.2% 112
2021
Q3 		$125M Buy
1,476,827
+16,252
+1% +$1.36M 0.26% 99
2021
Q2 		$122M Buy
1,460,575
+30,440
+2% +$2.49M 0.25% 103
2021
Q1 		$108M Buy
1,430,135
+159,813
+13% +$11.6M 0.23% 104
2020
Q4 		$86.8M Buy
1,270,322
+370,706
+41% +$24.1M 0.2% 116
2020
Q3 		$52.5M Buy
899,616
+25,899
+3% +$1.61M 0.13% 132
2020
Q2 		$56.8M Buy
873,717
+594,108
+212% +$37.4M 0.15% 122
2020
Q1 		$16.6M Buy
279,609
+46,329
+20% +$3.09M 0.06% 260
2019
Q4 		$17.3M Buy
+233,280
New +$16.4M 0.05% 315

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Ensign Peak Advisors's CVS Position: Q2 2026 in Review

Ensign Peak Advisors increased its CVS Health (CVS) stake by 2.8% in Q2 2026, buying an estimated $1.85M and bringing the position to 758,947 shares worth $78.5M. The position accounts for 0.13% of the portfolio, ranked #148.

Ensign Peak Advisors first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. The position peaked at $125M in Q3 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ensign Peak Advisors held 758,947 shares of CVS Health worth $78.5M as of Q2 2026.
  • Ensign Peak Advisors bought 20,767 CVS Health shares in Q2 2026, an estimated $1.85M.
  • CVS Health made up 0.13% of Ensign Peak Advisors's portfolio in Q2 2026, its #148 holding.
  • Ensign Peak Advisors first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's CVS Health position peaked at $125M in Q3 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.